Anagrelide treatment in early pregnancy in a patient with JAK2V617F-positive essential thrombocythemia: case report and literature review

Acta Haematol. 2009;122(4):221-2. doi: 10.1159/000253030. Epub 2009 Oct 29.
No abstract available

Publication types

  • Case Reports
  • Review

MeSH terms

  • Adult
  • Amino Acid Substitution
  • Female
  • Fibrinolytic Agents / therapeutic use*
  • Humans
  • Infant, Newborn
  • Janus Kinase 2 / genetics*
  • Point Mutation*
  • Pregnancy
  • Pregnancy Complications, Hematologic / drug therapy*
  • Pregnancy Outcome
  • Quinazolines / therapeutic use*
  • Thrombocythemia, Essential / complications*
  • Thrombocythemia, Essential / drug therapy*
  • Thrombocythemia, Essential / genetics

Substances

  • Fibrinolytic Agents
  • Quinazolines
  • JAK2 protein, human
  • Janus Kinase 2
  • anagrelide